Canine Blood Typing: DEA 1 and Bedside Decision Rules — GlobalVetCo

Canine Blood Typing: DEA 1 and Bedside Decision Rules

Why it matters: Correct typing lets you give the right unit and protects scarce DEA 1 negative red-cell stock for the dogs that truly need it.

Key takeaways

  • DEA 1 is the most important everyday canine red-cell antigen in practice.
  • Type before elective transfusion whenever time allows.
  • DEA 1 negative recipients should receive DEA 1 negative red cells to avoid sensitisation.
  • Weak positive results still mean antigen is present — treat as DEA 1 positive for donor selection logic.
  • Modern testing no longer relies on old DEA 1.1 / 1.2 / 1.3 subgroup labels.

What DEA 1 status means clinically

In an emergency, DEA 1 negative red cells can be used more broadly because they are less likely to sensitise against the DEA 1 antigen. That does not mean every patient should consume negative units. Most dogs are DEA 1 positive. If you type first, many patients can safely receive DEA 1 positive red cells, preserving negative inventory for negative recipients and true emergencies.

Bedside typing workflow

  1. Collect sample per kit instructions (usually EDTA).
  2. Run an in-house immunochromatographic or card/kit method validated for canine DEA 1.
  3. Read within the kit’s specified window (commonly about 5 minutes for rapid kits).
  4. Photograph/record the result in the clinical record.
  5. Choose product: match DEA 1 negative recipients to negative red cells when available.

Weak positives

As kit sensitivity improved, low-density DEA 1 antigen can read as a weak positive. Antigen is still present. Giving DEA 1 positive red cells to a weak-positive recipient is generally considered antigen-compatible on DEA 1 grounds. Giving DEA 1 positive cells to a true DEA 1 negative patient risks alloimmunisation.

History note (for exam brains)

Older literature described DEA 1.1, 1.2 and 1.3. Current monoclonal/immunofluorescence understanding treats these as density differences of DEA 1 rather than separate everyday clinical types. Practically: report and act on DEA 1 positive vs negative.

Red flags

  • Skipping typing “because the dog looks critical” when a 5-minute kit is available
  • Using the last DEA 1 negative unit for a DEA 1 positive stable case
  • Not documenting the kit lot/result image

Calculate dose → · Cross-match guide →

Educational only. GlobalVetCo clinical tools support veterinary professionals. Final decisions rest with the attending clinician. Not affiliated with Pet Blood Bank UK or any commercial blood bank.
返回博客